123 related articles for article (PubMed ID: 9855356)
1. Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion.
Azeh I; Mäder M; Smirnov A; Beuche W; Nau R; Weber F
Neurosci Lett; 1998 Nov; 256(3):127-30. PubMed ID: 9855356
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.
Kolb SA; Lahrtz F; Paul R; Leppert D; Nadal D; Pfister HW; Fontana A
J Neuroimmunol; 1998 Apr; 84(2):143-50. PubMed ID: 9628456
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia.
Conant K; McArthur JC; Griffin DE; Sjulson L; Wahl LM; Irani DN
Ann Neurol; 1999 Sep; 46(3):391-8. PubMed ID: 10482270
[TBL] [Abstract][Full Text] [Related]
4. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury.
Rosenberg GA; Dencoff JE; Correa N; Reiners M; Ford CC
Neurology; 1996 Jun; 46(6):1626-32. PubMed ID: 8649561
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
Destache CJ; Pakiz CB; Dash AK; Larsen C
Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
[TBL] [Abstract][Full Text] [Related]
6. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.
Friedberg MH; Glantz MJ; Klempner MS; Cole BF; Perides G
Cancer; 1998 Mar; 82(5):923-30. PubMed ID: 9486583
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of matrix metalloproteinases in bacterial meningitis.
Kieseier BC; Paul R; Koedel U; Seifert T; Clements JM; Gearing AJ; Pfister HW; Hartung HP
Brain; 1999 Aug; 122 ( Pt 8)():1579-87. PubMed ID: 10430840
[TBL] [Abstract][Full Text] [Related]
8. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.
Lindberg RL; Sorsa T; Tervahartiala T; Hoffmann F; Mellanen L; Kappos L; Schaad UB; Leib SL; Leppert D
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):304-17. PubMed ID: 16640649
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis.
Perides G; Charness ME; Tanner LM; Péter O; Satz N; Steere AC; Klempner MS
J Infect Dis; 1998 Feb; 177(2):401-8. PubMed ID: 9466528
[TBL] [Abstract][Full Text] [Related]
10. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P
J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329
[TBL] [Abstract][Full Text] [Related]
11. Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone.
Böttcher T; Ren H; Goiny M; Gerber J; Lykkesfeldt J; Kuhnt U; Lotz M; Bunkowski S; Werner C; Schau I; Spreer A; Christen S; Nau R
J Neurochem; 2004 Dec; 91(6):1450-60. PubMed ID: 15584921
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.
Umehara F; Okada Y; Fujimoto N; Abe M; Izumo S; Osame M
J Neuropathol Exp Neurol; 1998 Sep; 57(9):839-49. PubMed ID: 9737547
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
Leppert D; Leib SL; Grygar C; Miller KM; Schaad UB; Holländer GA
Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401
[TBL] [Abstract][Full Text] [Related]
14. Experimental pneumococcal meningitis: role of leukocytes in pathogenesis.
Ernst JD; Decazes JM; Sande MA
Infect Immun; 1983 Jul; 41(1):275-9. PubMed ID: 6862627
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloprotease-9 in cerebrospinal fluid correlates with disease activity in lymphomatous meningitis.
Wong ET; Lee D; Tam A; Gautam S; Wu JK
Clin Lymphoma Myeloma; 2007 Jan; 7(4):305-8. PubMed ID: 17324339
[TBL] [Abstract][Full Text] [Related]
16. Influence of the blood bacterial load on the meningeal inflammatory response in Streptococcus pneumoniae meningitis.
Østergaard C; O'Reilly T; Brandt C; Frimodt-Møller N; Lundgren JD
BMC Infect Dis; 2006 Apr; 6():78. PubMed ID: 16643642
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway.
Meli DN; Christen S; Leib SL
J Infect Dis; 2003 May; 187(9):1411-5. PubMed ID: 12717622
[TBL] [Abstract][Full Text] [Related]
18. Progression of hearing loss in experimental pneumococcal meningitis: correlation with cerebrospinal fluid cytochemistry.
Bhatt SM; Lauretano A; Cabellos C; Halpin C; Levine RA; Xu WZ; Nadol JB; Tuomanen E
J Infect Dis; 1993 Mar; 167(3):675-83. PubMed ID: 8440938
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
Liu X; Han Q; Sun R; Li Z
Brain Res; 2008 May; 1207():237-43. PubMed ID: 18374903
[TBL] [Abstract][Full Text] [Related]
20. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis.
Nau R; Zysk G; Reinert RR; Mergeryan H; Eiffert H; Prange HW
J Antimicrob Chemother; 1995 Dec; 36(6):997-1004. PubMed ID: 8821598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]